Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
World Journal of Surgery|January 7, 2015
Predicting early intrahepatic recurrence after curative resection of colorectal liver metastases with molecular markersMasato Narita, Elie Oussoultzoglou, Marie-Pierre Chenard, et al.
BMC Cancer|March 4, 2024
MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survivalSébastien Molière, Massimo Lodi, Suzanne Leblanc, et al.
International Journal of Cancer|March 9, 2010
Matrix metalloproteinase 11/stromelysin-3 exerts both activator and repressor functions during the hematogenous metastatic process in miceDavid Brasse, Carole Mathelin, Khadija Leroux, et al.
Molecular Medicine (Cambridge, Mass.)|October 3, 2002
Trefoil factor 1 (TFF1/pS2) deficiency activates the unfolded protein responseLuis-Fernando Torres, Sherif M Karam, Corinne Wendling, et al.
The EMBO Journal|April 6, 2017
STARD3 mediates endoplasmic reticulum-to-endosome cholesterol transport at membrane contact sitesLéa P Wilhelm, Corinne Wendling, Benoît Védie, et al.
Plos One|October 28, 2008
Tumor necrosis factor receptor-associated factor 4 is a dynamic tight junction-related shuttle protein involved in epithelium homeostasisValérie Kédinger, Fabien Alpy, Aurélie Baguet, et al.
Journal of Gastroenterology|July 12, 2002
Auxiliary partial orthotopic liver transplantation (APOLT) in the treatment of acute liver failureDaniel Jaeck, Karim Boudjema, Maxime Audet, et al.
Annals of Surgery|December 25, 2007
Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapyHiroshi Nakano, Elie Oussoultzoglou, Edoardo Rosso, et al.
Cancer Research|December 3, 2005
Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive frontKumari L Andarawewa, Elena R Motrescu, Marie-Pierre Chenard, et al.
Inflammatory Bowel Diseases|September 4, 2010
Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancerCamille Laurent, Magali Svrcek, Jean-François Flejou, et al.
Pageof 13